Federal Register / Vol. 80, No. 44 / Friday, March 6, 2015 / Notices 12157 

part of a Federal Government-wide 

effort to streamline the process to seek 

feedback from the public on service 

delivery, OMB is coordinating the 

development of the following proposed 

Generic Information Collection Request 

(Generic ICR): ‘‘Generic Clearance for 

the Collection of Qualitative Feedback 

on Agency Service Delivery’’ for 

approval under the Paperwork 

Reduction Act (PRA) (44 U.S.C. 3501 et 

seq.). This notice announces that CNCS 

intends to submit collections to OMB 

for approval and solicit comments on 

specific aspects for the proposed 

information collection. 

DATES: Comments must be submitted 

April 6, 2015. 

ADDRESSES: Comments may be 

submitted, identified by the title of the 

information collection activity, to the 

Office of Information and Regulatory 

Affairs, Attn: Ms. Sharon Mar, OMB 

Desk Officer for CNCS, by any of the 

following two methods within 30 days 

from the date of publication in the 

Federal Register: 

(1) By fax to: 202–395–6974, 

Attention: Ms. Sharon Mar, OMB Desk 

Officer for CNCS; and 

(2) Electronically by email to: smar@

omb.eop.gov. 

FOR FURTHER INFORMATION CONTACT: To 

request additional information, please 

contact Amy Borgstrom, Associate 

Director of Policy, at 202–606–6930 or 

email to aborgstrom@cns.gov. 

Individuals who use a 

telecommunications device for the deaf 

(TTY–TDD) may call 1–800–833–3722 

between 8:00 a.m. and 8:00 p.m. Eastern 

Time, Monday through Friday. 

SUPPLEMENTARY INFORMATION: The OMB 

is particularly interested in comments 

which: 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of CNCS, including whether 

the information will have practical 

utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

• Propose ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and 

• Propose ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

through the use of appropriate 

automated, electronic, mechanical, or 

other technological collection 

techniques or other forms of information 

technology. 

Comments 

No comments were received in 

response to the 60-day notice published 

in the Federal Register of March 5, 2014 

(79 FR 12493). 

Title: Generic Clearance for the 

Collection of Qualitative Feedback on 

Agency Service Delivery. 

Abstract: The information collection 

activity will garner qualitative customer 

and stakeholder feedback in an efficient, 

timely manner, in accordance with the 

Administration’s commitment to 

improving service delivery. By 

qualitative feedback we mean 

information that provides useful 

insights on perceptions and opinions, 

but are not statistical surveys that yield 

quantitative results that can be 

generalized to the population of study. 

This feedback will provide insights into 

customer or stakeholder perceptions, 

experiences and expectations, provide 

an early warning of issues with service, 

or focus attention on areas where 

communication, training or changes in 

operations might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative and 

actionable communications between the 

Agency and its customers and 

stakeholders. It will also allow feedback 

to contribute directly to the 

improvement of program management. 

Feedback collected under this generic 

clearance will provide useful 

information, but it will not yield data 

that can be generalized to the overall 

population. This type of generic 

clearance for qualitative information 

will not be used for quantitative 

information collections that are 

designed to yield reliably actionable 

results, such as monitoring trends over 

time or documenting program 

performance. Such data uses require 

more rigorous designs that address the 

target population to which 

generalizations will be made, the 

sampling frame, the sample design 

(including stratification and clustering), 

the precision requirements or power 

calculations that justify the proposed 

sample size, the expected response rate, 

methods for assessing potential nonresponse bias, the protocols for data 

collection, and any testing procedures 

that were or will be undertaken prior 

fielding the study. Depending on the 

degree of influence the results are likely 

to have, such collections may still be 

eligible for submission for other generic 

mechanisms that are designed to yield 

quantitative results. 

Type of Review: Renewal. 

Affected Public: Individuals and 

Households, Businesses and 

Organizations, State, Local or Tribal 

Government. 

Respondents: 10,000. 

Annual responses: 10,000. 

Frequency of Response: Once per 

request. 

Average minutes per response: 10. 

Burden hours: 1,667. 

An agency may not conduct or 

sponsor, and a person is not required to 

respond to, a collection of information 

unless it displays a currently valid 

Office of Management and Budget 

Control Number. 

Dated: March 3, 2015. 

Amy Borgstrom, 

Associate Director of Policy. 

[FR Doc. 2015–05300 Filed 3–5–15; 8:45 am] 

BILLING CODE 6050–28–P 

DEPARTMENT OF DEFENSE 

Defense Acquisition Regulations 

System 

[Docket No. DARS–2015–0012] 

Acquisition of Items for Which Federal 

Prison Industries Has a Significant 

Market Share 

ACTION: Notice. 

SUMMARY: DoD is publishing the 

updated annual list of product 

categories for which the Federal Prison 

Industries’ share of the DoD market is 

greater than five percent. 

DATES: Effective Date: March 29, 2015. 

FOR FURTHER INFORMATION CONTACT: 

Sheila Harris, telephone 703–614–1333. 

SUPPLEMENTARY INFORMATION: 

I. Background: On November 19, 

2009, a final rule was published at 74 

FR 59914 which amended the Defense 

Federal Acquisition Regulation 

Supplement (DFARS) subpart 208.6, to 

implement section 827 of the National 

Defense Authorization Act (NDAA) for 

Fiscal Year 2008, Public Law 110–181. 

Section 827 changed DoD competition 

requirements for purchases from Federal 

Prison Industries, Inc. (FPI) by requiring 

DoD to publish an annual list of product 

categories for which FPI’s share of the 

DoD market was greater than five 

percent, based on the most recent fiscal 

year data available. Product categories 

on the current list, and the products 

within each identified product category, 

must be procured using competitive or 

fair opportunity procedures in 

accordance with DFARS 208.602–70. 

The Director, Defense Procurement 

and Acquisition Policy (DPAP) issued a 

memorandum dated February 27, 2015, 

that provides the current list of product 

mstockstill on DSK4VPTVN1PROD with NOTICES

12158 Federal Register / Vol. 80, No. 44 / Friday, March 6, 2015 / Notices 

categories for which FPI’s share of the 

DOD market is greater than five percent 

based on Fiscal Year 2014 data from the 

Federal Procurement Data System. The 

product categories to be competed 

effective March 29, 2015, are the 

following: 

• 3990 (Miscellaneous Materials 

Handling Equipment) 

• 5210 (Measuring Tools, Craftsmen’s) 

• 7110 (Office Furniture) 

• 7125 (Cabinets, Lockers, Bins and 

Shelving) 

• 7230 (Draperies, Awnings, and 

Shades) 

• 8405 (Outerwear, Men’s) 

• 8410 (Outerwear, Women’s) 

• 8415 (Clothing, Special Purpose) 

The DPAP memorandum with the 

current list of product categories for 

which FPI has a significant market share 

is posted at: http://www.acq.osd.mil/

dpap/policy/policyvault/USA001110- 

15-DPAP.pdf. 

The statute as implemented also 

requires DoD to— 

(1) Include FPI in the solicitation 

process for these items; a timely offer 

from FPI must be considered; and award 

procedures must be followed in 

accordance with existing policy at 

Federal Acquisition Regulation (FAR) 

8.602(a)(4)(ii) through (v); 

(2) Continue to be make acquisitions, 

in accordance with FAR Subpart 8.6, for 

items from product categories for which 

FPI does not have a significant market 

share. FAR 8.602 requires agencies to 

conduct market research and make a 

written comparability determination, at 

the discretion of the contracting officer. 

Competitive (or fair opportunity) 

procedures are appropriate if the FPI 

product is not comparable in terms of 

price, quality, or time of delivery; and 

(3) Section 827 allows modification of 

the published list if DoD subsequently 

determines that new data requires 

adding or omitting a product category 

from the list. 

Manuel Quinones, 

Editor, Defense Acquisition Regulations 

Council. 

[FR Doc. 2015–05270 Filed 3–5–15; 8:45 am] 

BILLING CODE 5001–06–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Uniform Formulary Beneficiary 

Advisory Panel; Notice of Federal 

Advisory Committee Meeting 

AGENCY: Assistant Secretary of Defense 

(Health Affairs), DoD. 

ACTION: Notice of meeting. 

SUMMARY: The Department of Defense is 

publishing this notice to announce a 

Federal Advisory Committee meeting of 

the Uniform Formulary Beneficiary 

Advisory Panel (hereafter referred to as 

the Panel). 

DATES: Thursday, March 26, 2015, from 

9 a.m. to 1 p.m. 

ADDRESSES: Naval Heritage Center 

Theater, 701 Pennsylvania Avenue NW., 

Washington, DC 20004. 

FOR FURTHER INFORMATION CONTACT: Mr. 

William H. Blanche, Alternate DFO, 

Uniform Formulary Beneficiary 

Advisory Panel, 7700 Arlington 

Boulevard, Suite 5101, Falls Church, VA 

22042–5101. Telephone: (703) 681– 

2890. Fax: (703) 681–1940. Email 

Address: Baprequests@dha.mil. 

SUPPLEMENTARY INFORMATION: This 

meeting is being held under the 

provisions of the Federal Advisory 

Committee Act of 1972 (title 5, United 

States Code (U.S.C.), Appendix, as 

amended) and the Government in the 

Sunshine Act of 1976 (5 U.S.C. 552b, as 

amended). 

Purpose of Meeting: The Panel will 

review and comment on 

recommendations made to the Director 

of Defense Health Agency, by the 

Pharmacy and Therapeutics Committee, 

regarding the Uniform Formulary. 

Meeting Agenda 

1. Sign-In 

2. Welcome and Opening Remarks 

3. Public Citizen Comments 

4. Scheduled Therapeutic Class Reviews 

(Comments will follow each agenda 

item) 

a. Pulmonary Artery Hypertension 

b. Transmucosal Immediate Release 

Fentanyl Products 

c. Oral Oncology Agents—Prostate I & II 

5. Designated Newly Approved Drugs in 

Already-Reviewed Classes 

6. Pertinent Utilization Management 

Issues 

7. Panel Discussions and Vote 

Meeting Accessibility: Pursuant to 5 

U.S.C. 552b, as amended, and 41 Code 

of Federal Regulations (CFR) 102–3.140 

through 102–3.165, and the availability 

of space, this meeting is open to the 

public. Seating is limited and will be 

provided only to the first 220 people 

signing-in. All persons must sign-in 

legibly. 

Administrative Work Meeting: Prior to 

the public meeting, the Panel will 

conduct an Administrative Work 

Meeting from 8:30 a.m. to 9 a.m. to 

discuss administrative matters of the 

Panel. The Administrative Work 

Meeting will be held at the Naval 

Heritage Center, 701 Pennsylvania 

Avenue NW., Washington, DC 20004. 

Pursuant to 41 CFR 102–3.160, the 

Administrative Work Meeting will be 

closed to the public. 

Written Statements: Pursuant to 41 

CFR 102–3.140, the public or interested 

organizations may submit written 

statements to the membership of the 

Panel at any time or in response to the 

stated agenda of a planned meeting. 

Written statements should be submitted 

to the Panel’s Designated Federal Officer 

(DFO). The DFO’s contact information 

can be obtained from the General 

Services Administration’s Federal 

Advisory Committee Act Database at 

http://facadatabase.gov/. 

Written statements that do not pertain 

to the scheduled meeting of the Panel 

may be submitted at any time. However, 

if individual comments pertain to a 

specific topic being discussed at a 

planned meeting, then these statements 

must be submitted no later than 5 

business days prior to the meeting in 

question. The DFO will review all 

submitted written statements and 

provide copies to all the committee 

members. 

Public Comments: In addition to 

written statements, the Panel will set 

aside 1 hour for individuals or 

interested groups to address the Panel. 

To ensure consideration of their 

comments, individuals and interested 

groups should submit written 

statements as outlined in this notice; but 

if they still want to address the Panel, 

then they will be afforded the 

opportunity to register to address the 

Panel. The Panel’s DFO will have a 

‘‘Sign-Up Roster’’ available at the Panel 

meeting for registration on a first-come, 

first-serve basis. Those wishing to 

address the Panel will be given no more 

than 5 minutes to present their 

comments, and at the end of the 1 hour 

time period, no further public 

comments will be accepted. Anyone 

who signs-up to address the Panel, but 

is unable to do so due to the time 

limitation, may submit their comments 

in writing; however, they must 

understand that their written comments 

may not be reviewed prior to the Panel’s 

deliberation. 

To ensure timeliness of comments for 

the official record, the Panel encourages 

that individuals and interested groups 

consider submitting written statements 

instead of addressing the Panel. 

Dated: March 3, 2015. 

Aaron Siegel, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2015–05205 Filed 3–5–15; 8:45 am] 

BILLING CODE 5001–06–P 

mstockstill on DSK4VPTVN1PROD with NOTICES